Skip to content

Effectiveness of Mindful Self-Compassion treatment program and spouse support in women with breast cancer

Investigating the Effectiveness of Mindful Self-Compassion treatment program and spouse support on psychopathology symptoms in women with breast cancer: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241129063890N1
Enrollment
45
Registered
2025-03-16
Start date
2025-04-26
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Mindful Self-Compassion tretment program was developed by Kristen Neff and Christopher Germer in 2008. The treatment protocol consists of 8 weekly 90-minute group sessions. The session

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Ability to read and write and participate in treatment sessions Have informed consent to participate in the research and complete the informed consent form No other chronic physical illnesses such as uncontrolled diabetes and untreated thyroid disorders No severe mental illnesses including schizophrenia spectrum disorders, bipolar I disorder, and severe personality disorders No regular psychotherapy sessions for six months prior to the start of treatment No history of other cancer and have received a pathological diagnosis of breast cancer No problems with hearing and vision No history of drug use The patient is from the lumpectomy group and is in the radiotherapy phase

Exclusion criteria

Exclusion criteria: The disease is not in an acute stage. Patient's unwillingness to start treatment Have at least a diploma education and a psychological mindset to accept psychological and therapeutic concepts

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Pre-test, post-test and 2-month follow-up. Method of measurement: Depression Questionnaire (DASS-21).;Body Image. Timepoint: Pre-test, post-test and 2-month follow-up. Method of measurement: Body Image Shame Scale Questionnaire(BISS).;Demoralization. Timepoint: Pre-test, post-test and 2-month follow-up. Method of measurement: Kisan Demoralization Questionnaire (DS-II).;Anxiety. Timepoint: Pre-test, post-test and 2-month follow-up. Method of measurement: Anxiety Questionnaire (DASS-21).;Stress. Timepoint: Pre-test, post-test and 2-month follow-up. Method of measurement: Stress Questionnaire (DASS-21).

Secondary

MeasureTime frame
Sleep quality. Timepoint: Pre test, Post test, and 2-month follow-up. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Body compassion. Timepoint: Pre test, Post test, and 2-month follow-up. Method of measurement: Altman Body Compassion Scale (BSC).;Engaged living. Timepoint: Pre test, Post test, and 2-month follow-up. Method of measurement: Trumpeter Engaged Living Scale (ELS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfshin Shojaei

Kermanshah University of Medical Sciences

afshinshojaei10@gmail.com+98 914 221 3985

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026